Abnormal Clots and All-Cause Mortality During the Pandemic Experiment: Five Doses of COVID-19 Vaccine Are Evidently Lethal to Nearly All Medicare Participants

Daniel Santiago, J. Oller
{"title":"Abnormal Clots and All-Cause Mortality During the Pandemic Experiment: Five Doses of COVID-19 Vaccine Are Evidently Lethal to Nearly All Medicare Participants","authors":"Daniel Santiago, J. Oller","doi":"10.56098/ijvtpr.v3i1.73","DOIUrl":null,"url":null,"abstract":"Nyström and Hammarström (2022) found 7 segments in the bio-active SARS-CoV-2 spike protein that can produce abnormal proteinaceous (fibrinaloid) clots according to the Waltz algorithm. In vitro results confirmed the Waltz predictions. If the spike coding sequence was captured in the BNT162b2, Moderna, and other injectables, as claimed by the manufacturers, the clot producing segments are present in them too. Mainstream medical publications claim that SARS-CoV-2 infection can cause abnormal clotting, especially in “long COVID”. Telling evidence from Medicare data shows a decreasing life expectancy with each dose of COVID-19 “vaccine” — 1 dose is worse than 0, and 2 worse than 1, etc. In Connecticut, 26,091 Medicare participants who died before December 31, 2022, but never took a COVID injection, on the average, survived 428 days after the middle of the pandemic period (July 27, 2020). By then nearly all of them must have been exposed to and/or infected by some SARS-CoV-2 variant — hence, the CDC urging to take the “vaccines”. By contrast, 108,156 Medicare patients across the US who died before January 1, 2023, after just 1 dose of COVID-19 “vaccine”, survived only 308 days — a loss of 119.9 days on the average. Connecticut participants, 23,248 of them, who received 2 to 5 doses, on the average, lost an additional 62 days of life-expectancy with each booster. It follows that 5 boosters times 62 days reduces the average remaining 308 days left-to-live after dose 1 by 310 days. So, nearly all the Medicare participants will have been dead for 2 days by booster 4 (dose 5). The upshot is that 5 doses, on the average, will kill all the Medicare participants who accept the advice of the CDC.[1] For 157,495 of the 65 and older Medicare population studied here — people supposedly most apt to benefit from COVID-19 injectables — days-left-to-live shrinks by 74 days, on the average, with each dose. It is also likely that the COVID-19 injectables are partly, maybe wholly, responsible for the unnatural clots found by treating physicians, pathologists, and embalmers in living and dead recipients of the experimental injectables. It is certain is that the injectables are increasing all-cause mortality across the globe. \n[1] In the dataset from Connecticut, only 7 of 57,261 Medicare participants (7/57261 = 0.000122), or about 1.22 persons in 10,000 survived 5 doses during the experimental pandemic in order to take a 6th dose. Those who did so died, on the average, in 34 days. Only 1 participant survived 6 doses to receive a 7th and died within 69 days at the age of 68.  ","PeriodicalId":391540,"journal":{"name":"International Journal of Vaccine Theory, Practice, and Research","volume":"144 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Vaccine Theory, Practice, and Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.56098/ijvtpr.v3i1.73","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Nyström and Hammarström (2022) found 7 segments in the bio-active SARS-CoV-2 spike protein that can produce abnormal proteinaceous (fibrinaloid) clots according to the Waltz algorithm. In vitro results confirmed the Waltz predictions. If the spike coding sequence was captured in the BNT162b2, Moderna, and other injectables, as claimed by the manufacturers, the clot producing segments are present in them too. Mainstream medical publications claim that SARS-CoV-2 infection can cause abnormal clotting, especially in “long COVID”. Telling evidence from Medicare data shows a decreasing life expectancy with each dose of COVID-19 “vaccine” — 1 dose is worse than 0, and 2 worse than 1, etc. In Connecticut, 26,091 Medicare participants who died before December 31, 2022, but never took a COVID injection, on the average, survived 428 days after the middle of the pandemic period (July 27, 2020). By then nearly all of them must have been exposed to and/or infected by some SARS-CoV-2 variant — hence, the CDC urging to take the “vaccines”. By contrast, 108,156 Medicare patients across the US who died before January 1, 2023, after just 1 dose of COVID-19 “vaccine”, survived only 308 days — a loss of 119.9 days on the average. Connecticut participants, 23,248 of them, who received 2 to 5 doses, on the average, lost an additional 62 days of life-expectancy with each booster. It follows that 5 boosters times 62 days reduces the average remaining 308 days left-to-live after dose 1 by 310 days. So, nearly all the Medicare participants will have been dead for 2 days by booster 4 (dose 5). The upshot is that 5 doses, on the average, will kill all the Medicare participants who accept the advice of the CDC.[1] For 157,495 of the 65 and older Medicare population studied here — people supposedly most apt to benefit from COVID-19 injectables — days-left-to-live shrinks by 74 days, on the average, with each dose. It is also likely that the COVID-19 injectables are partly, maybe wholly, responsible for the unnatural clots found by treating physicians, pathologists, and embalmers in living and dead recipients of the experimental injectables. It is certain is that the injectables are increasing all-cause mortality across the globe. [1] In the dataset from Connecticut, only 7 of 57,261 Medicare participants (7/57261 = 0.000122), or about 1.22 persons in 10,000 survived 5 doses during the experimental pandemic in order to take a 6th dose. Those who did so died, on the average, in 34 days. Only 1 participant survived 6 doses to receive a 7th and died within 69 days at the age of 68.  
大流行实验期间的异常凝块和全因死亡率:五剂COVID-19疫苗显然对几乎所有医疗保险参与者都是致命的
Nyström和Hammarström(2022)根据华尔兹算法发现,具有生物活性的SARS-CoV-2刺突蛋白中有7个片段可以产生异常蛋白(纤维蛋白样蛋白)凝块。体外实验结果证实了瓦尔兹的预测。如果刺突编码序列在BNT162b2、Moderna和其他注射剂中被捕获,正如制造商所声称的那样,凝块产生片段也存在于它们中。主流医学出版物声称,SARS-CoV-2感染可导致凝血异常,特别是“长COVID”。来自医疗保险数据的有力证据显示,每注射一剂COVID-19“疫苗”,预期寿命就会缩短——1剂比0剂差,2剂比1剂差,等等。在康涅狄格州,2022年12月31日之前死亡但从未注射过COVID疫苗的26,091名医疗保险参与者在大流行中期(2020年7月27日)后平均存活了428天。到那时,几乎所有人都必须接触过和/或感染过一些SARS-CoV-2变体,因此,疾病预防控制中心敦促接种“疫苗”。相比之下,在2023年1月1日之前,美国108156名医疗保险患者在接种了1剂COVID-19“疫苗”后死亡,仅存活了308天,平均减少了119.9天。康涅狄格的23248名参与者接受了2至5剂疫苗,平均而言,每次注射后预期寿命增加了62天。由此可见,5次助推器乘以62天,使第1次剂量后的平均剩余308天减少310天。因此,几乎所有的医疗保险参与者在接种强化剂4(剂量5)后两天内都会死亡。结果是,平均而言,5剂就会杀死所有接受疾病预防控制中心建议的医疗保险参与者。[1]在这里研究的65岁及以上的医疗保险人群中,157495人——据说最容易从COVID-19注射剂中受益的人——平均每注射一剂,剩余寿命会缩短74天。治疗医生、病理学家和防腐师在接受实验性注射的活人和死人身上发现的非自然凝块,也可能部分(甚至全部)是COVID-19注射剂造成的。可以肯定的是,注射药物正在增加全球的全因死亡率。[1]在康涅狄格州的数据集中,57,261名医疗保险参与者中只有7人(7/57261 = 0.000122),或10,000人中约有1.22人在实验性大流行期间存活5剂,以便服用第6剂。这样做的人平均在34天内死亡。只有1名参与者在接受第7次注射时存活了6次,并在69天内死亡,享年68岁。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信